Polyclonal Antibody to Fibronectin Type III Domain Containing Protein 5 (FNDC5)

FRCP2; Irisin; Fibronectin type III repeat-containing protein 2

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against FNDC5. It has been selected for its ability to recognize FNDC5 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 1:50-400
Immunocytochemistry in formalin fixed cells: 1:50-500
Immunohistochemistry in formalin fixed frozen section: 1:50-500
Immunohistochemistry in paraffin section: 1:10-100
Enzyme-linked Immunosorbent Assay: 1:100-1:5000
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Reference
Diabetes Research and Clinical Practice Serum irisin levels in new-onset type 2 diabetes PubMed: 23369227
Journal of diabetes and its complications Lower circulating irisin is associated with type 2 diabetes mellitus Pubmed: 23619195
Horm Metab Res. Inconsistency in circulating irisin levels: what is really happening Pubmed:24459033
Int J Obes (Lond). Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice Pubmed:25199621
Molecular and Cellular Endocrinology Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice Pubmed:25576856
journal of diabetes Lower irisin level in patients with type 2 diabetes mellitus: A case-control study and meta-analysis PubMed: 25494632
The Journal of Maternal-Fetal & Neonatal Medicine Maternal circulating levels of irisin in intrahepatic cholestasis of pregnancy PubMed: 26689349
Hormone and Metabolic Research Lower Circulating Irisin Level in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis Pubmed:27300472
Nature Reviews Endocrinology Physiology and role of irisin in glucose homeostasis. pubmed:28211512
Journal of Molecular and Cellular Cardiology Irisin improves perivascular adipose tissue dysfunction via regulation of the heme oxygenase-1/adiponectin axis in diet-induced obese mice pubmed:27638193
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPN576Hu02 Recombinant Fibronectin Type III Domain Containing Protein 5 (FNDC5) Positive Control; Immunogen; SDS-PAGE; WB.
EPN576Hu61 Eukaryotic Fibronectin Type III Domain Containing Protein 5 (FNDC5) Positive Control; Immunogen; SDS-PAGE; WB.
RPN576Hu01 Recombinant Fibronectin Type III Domain Containing Protein 5 (FNDC5) Positive Control; Immunogen; SDS-PAGE; WB.
APN576Hu01 Active Fibronectin Type III Domain Containing Protein 5 (FNDC5) Cell culture; Activity Assays.
APN576Hu61 Active Fibronectin Type III Domain Containing Protein 5 (FNDC5) Cell culture; Activity Assays.
PAN576Hu02 Polyclonal Antibody to Fibronectin Type III Domain Containing Protein 5 (FNDC5) WB; IHC; ICC; IP.
PAN576Hu01 Polyclonal Antibody to Fibronectin Type III Domain Containing Protein 5 (FNDC5) WB; IHC; ICC; IP.
LAN576Hu71 Biotin-Linked Polyclonal Antibody to Fibronectin Type III Domain Containing Protein 5 (FNDC5) WB; IHC; ICC.
SEN576Hu ELISA Kit for Fibronectin Type III Domain Containing Protein 5 (FNDC5) Enzyme-linked immunosorbent assay for Antigen Detection.